Medical Care
Global Central Nervous System Biomarkers Market Research Report 2025
- Sep 18, 25
- ID: 507554
- Pages: 82
- Figures: 84
- Views: 11
This report aims to provide a comprehensive presentation of the global market for Central Nervous System Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Central Nervous System Biomarkers.
The Central Nervous System Biomarkers market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Central Nervous System Biomarkers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Central Nervous System Biomarkers companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Takeda Pharmaceutical
Thermo Fisher Scientific
Avacta Group
Diagenic Asa
Banyan Biomarkers
Eli Lilly
Pfizer
Alseres Pharmaceuticals
Acumen pharmaceuticals
EKF Diagnostics
Abiant
Myriad RBM
Aposense
Segment by Type
Safety Biomarker
Efficacy Biomarker
Validation Biomarker
Other
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Central Nervous System Biomarkers company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Central Nervous System Biomarkers market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Central Nervous System Biomarkers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Central Nervous System Biomarkers companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Takeda Pharmaceutical
Thermo Fisher Scientific
Avacta Group
Diagenic Asa
Banyan Biomarkers
Eli Lilly
Pfizer
Alseres Pharmaceuticals
Acumen pharmaceuticals
EKF Diagnostics
Abiant
Myriad RBM
Aposense
Segment by Type
Safety Biomarker
Efficacy Biomarker
Validation Biomarker
Other
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Central Nervous System Biomarkers company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Central Nervous System Biomarkers Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Safety Biomarker
1.2.3 Efficacy Biomarker
1.2.4 Validation Biomarker
1.2.5 Other
1.3 Market by Application
1.3.1 Global Central Nervous System Biomarkers Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Central Nervous System Biomarkers Market Perspective (2020-2031)
2.2 Global Central Nervous System Biomarkers Growth Trends by Region
2.2.1 Global Central Nervous System Biomarkers Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Central Nervous System Biomarkers Historic Market Size by Region (2020-2025)
2.2.3 Central Nervous System Biomarkers Forecasted Market Size by Region (2026-2031)
2.3 Central Nervous System Biomarkers Market Dynamics
2.3.1 Central Nervous System Biomarkers Industry Trends
2.3.2 Central Nervous System Biomarkers Market Drivers
2.3.3 Central Nervous System Biomarkers Market Challenges
2.3.4 Central Nervous System Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Central Nervous System Biomarkers Players by Revenue
3.1.1 Global Top Central Nervous System Biomarkers Players by Revenue (2020-2025)
3.1.2 Global Central Nervous System Biomarkers Revenue Market Share by Players (2020-2025)
3.2 Global Central Nervous System Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Central Nervous System Biomarkers Revenue
3.4 Global Central Nervous System Biomarkers Market Concentration Ratio
3.4.1 Global Central Nervous System Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Central Nervous System Biomarkers Revenue in 2024
3.5 Global Key Players of Central Nervous System Biomarkers Head office and Area Served
3.6 Global Key Players of Central Nervous System Biomarkers, Product and Application
3.7 Global Key Players of Central Nervous System Biomarkers, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Central Nervous System Biomarkers Breakdown Data by Type
4.1 Global Central Nervous System Biomarkers Historic Market Size by Type (2020-2025)
4.2 Global Central Nervous System Biomarkers Forecasted Market Size by Type (2026-2031)
5 Central Nervous System Biomarkers Breakdown Data by Application
5.1 Global Central Nervous System Biomarkers Historic Market Size by Application (2020-2025)
5.2 Global Central Nervous System Biomarkers Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Central Nervous System Biomarkers Market Size (2020-2031)
6.2 North America Central Nervous System Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Central Nervous System Biomarkers Market Size by Country (2020-2025)
6.4 North America Central Nervous System Biomarkers Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Central Nervous System Biomarkers Market Size (2020-2031)
7.2 Europe Central Nervous System Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Central Nervous System Biomarkers Market Size by Country (2020-2025)
7.4 Europe Central Nervous System Biomarkers Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Central Nervous System Biomarkers Market Size (2020-2031)
8.2 Asia-Pacific Central Nervous System Biomarkers Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Central Nervous System Biomarkers Market Size by Region (2020-2025)
8.4 Asia-Pacific Central Nervous System Biomarkers Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Central Nervous System Biomarkers Market Size (2020-2031)
9.2 Latin America Central Nervous System Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Central Nervous System Biomarkers Market Size by Country (2020-2025)
9.4 Latin America Central Nervous System Biomarkers Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Central Nervous System Biomarkers Market Size (2020-2031)
10.2 Middle East & Africa Central Nervous System Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Central Nervous System Biomarkers Market Size by Country (2020-2025)
10.4 Middle East & Africa Central Nervous System Biomarkers Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Central Nervous System Biomarkers Introduction
11.1.4 Merck Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.1.5 Merck Recent Development
11.2 Takeda Pharmaceutical
11.2.1 Takeda Pharmaceutical Company Details
11.2.2 Takeda Pharmaceutical Business Overview
11.2.3 Takeda Pharmaceutical Central Nervous System Biomarkers Introduction
11.2.4 Takeda Pharmaceutical Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.2.5 Takeda Pharmaceutical Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Central Nervous System Biomarkers Introduction
11.3.4 Thermo Fisher Scientific Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Avacta Group
11.4.1 Avacta Group Company Details
11.4.2 Avacta Group Business Overview
11.4.3 Avacta Group Central Nervous System Biomarkers Introduction
11.4.4 Avacta Group Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.4.5 Avacta Group Recent Development
11.5 Diagenic Asa
11.5.1 Diagenic Asa Company Details
11.5.2 Diagenic Asa Business Overview
11.5.3 Diagenic Asa Central Nervous System Biomarkers Introduction
11.5.4 Diagenic Asa Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.5.5 Diagenic Asa Recent Development
11.6 Banyan Biomarkers
11.6.1 Banyan Biomarkers Company Details
11.6.2 Banyan Biomarkers Business Overview
11.6.3 Banyan Biomarkers Central Nervous System Biomarkers Introduction
11.6.4 Banyan Biomarkers Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.6.5 Banyan Biomarkers Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Details
11.7.2 Eli Lilly Business Overview
11.7.3 Eli Lilly Central Nervous System Biomarkers Introduction
11.7.4 Eli Lilly Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.7.5 Eli Lilly Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Central Nervous System Biomarkers Introduction
11.8.4 Pfizer Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.8.5 Pfizer Recent Development
11.9 Alseres Pharmaceuticals
11.9.1 Alseres Pharmaceuticals Company Details
11.9.2 Alseres Pharmaceuticals Business Overview
11.9.3 Alseres Pharmaceuticals Central Nervous System Biomarkers Introduction
11.9.4 Alseres Pharmaceuticals Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.9.5 Alseres Pharmaceuticals Recent Development
11.10 Acumen pharmaceuticals
11.10.1 Acumen pharmaceuticals Company Details
11.10.2 Acumen pharmaceuticals Business Overview
11.10.3 Acumen pharmaceuticals Central Nervous System Biomarkers Introduction
11.10.4 Acumen pharmaceuticals Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.10.5 Acumen pharmaceuticals Recent Development
11.11 EKF Diagnostics
11.11.1 EKF Diagnostics Company Details
11.11.2 EKF Diagnostics Business Overview
11.11.3 EKF Diagnostics Central Nervous System Biomarkers Introduction
11.11.4 EKF Diagnostics Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.11.5 EKF Diagnostics Recent Development
11.12 Abiant
11.12.1 Abiant Company Details
11.12.2 Abiant Business Overview
11.12.3 Abiant Central Nervous System Biomarkers Introduction
11.12.4 Abiant Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.12.5 Abiant Recent Development
11.13 Myriad RBM
11.13.1 Myriad RBM Company Details
11.13.2 Myriad RBM Business Overview
11.13.3 Myriad RBM Central Nervous System Biomarkers Introduction
11.13.4 Myriad RBM Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.13.5 Myriad RBM Recent Development
11.14 Aposense
11.14.1 Aposense Company Details
11.14.2 Aposense Business Overview
11.14.3 Aposense Central Nervous System Biomarkers Introduction
11.14.4 Aposense Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.14.5 Aposense Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Central Nervous System Biomarkers Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Safety Biomarker
1.2.3 Efficacy Biomarker
1.2.4 Validation Biomarker
1.2.5 Other
1.3 Market by Application
1.3.1 Global Central Nervous System Biomarkers Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Central Nervous System Biomarkers Market Perspective (2020-2031)
2.2 Global Central Nervous System Biomarkers Growth Trends by Region
2.2.1 Global Central Nervous System Biomarkers Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Central Nervous System Biomarkers Historic Market Size by Region (2020-2025)
2.2.3 Central Nervous System Biomarkers Forecasted Market Size by Region (2026-2031)
2.3 Central Nervous System Biomarkers Market Dynamics
2.3.1 Central Nervous System Biomarkers Industry Trends
2.3.2 Central Nervous System Biomarkers Market Drivers
2.3.3 Central Nervous System Biomarkers Market Challenges
2.3.4 Central Nervous System Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Central Nervous System Biomarkers Players by Revenue
3.1.1 Global Top Central Nervous System Biomarkers Players by Revenue (2020-2025)
3.1.2 Global Central Nervous System Biomarkers Revenue Market Share by Players (2020-2025)
3.2 Global Central Nervous System Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Central Nervous System Biomarkers Revenue
3.4 Global Central Nervous System Biomarkers Market Concentration Ratio
3.4.1 Global Central Nervous System Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Central Nervous System Biomarkers Revenue in 2024
3.5 Global Key Players of Central Nervous System Biomarkers Head office and Area Served
3.6 Global Key Players of Central Nervous System Biomarkers, Product and Application
3.7 Global Key Players of Central Nervous System Biomarkers, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Central Nervous System Biomarkers Breakdown Data by Type
4.1 Global Central Nervous System Biomarkers Historic Market Size by Type (2020-2025)
4.2 Global Central Nervous System Biomarkers Forecasted Market Size by Type (2026-2031)
5 Central Nervous System Biomarkers Breakdown Data by Application
5.1 Global Central Nervous System Biomarkers Historic Market Size by Application (2020-2025)
5.2 Global Central Nervous System Biomarkers Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Central Nervous System Biomarkers Market Size (2020-2031)
6.2 North America Central Nervous System Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Central Nervous System Biomarkers Market Size by Country (2020-2025)
6.4 North America Central Nervous System Biomarkers Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Central Nervous System Biomarkers Market Size (2020-2031)
7.2 Europe Central Nervous System Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Central Nervous System Biomarkers Market Size by Country (2020-2025)
7.4 Europe Central Nervous System Biomarkers Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Central Nervous System Biomarkers Market Size (2020-2031)
8.2 Asia-Pacific Central Nervous System Biomarkers Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Central Nervous System Biomarkers Market Size by Region (2020-2025)
8.4 Asia-Pacific Central Nervous System Biomarkers Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Central Nervous System Biomarkers Market Size (2020-2031)
9.2 Latin America Central Nervous System Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Central Nervous System Biomarkers Market Size by Country (2020-2025)
9.4 Latin America Central Nervous System Biomarkers Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Central Nervous System Biomarkers Market Size (2020-2031)
10.2 Middle East & Africa Central Nervous System Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Central Nervous System Biomarkers Market Size by Country (2020-2025)
10.4 Middle East & Africa Central Nervous System Biomarkers Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Central Nervous System Biomarkers Introduction
11.1.4 Merck Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.1.5 Merck Recent Development
11.2 Takeda Pharmaceutical
11.2.1 Takeda Pharmaceutical Company Details
11.2.2 Takeda Pharmaceutical Business Overview
11.2.3 Takeda Pharmaceutical Central Nervous System Biomarkers Introduction
11.2.4 Takeda Pharmaceutical Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.2.5 Takeda Pharmaceutical Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Central Nervous System Biomarkers Introduction
11.3.4 Thermo Fisher Scientific Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Avacta Group
11.4.1 Avacta Group Company Details
11.4.2 Avacta Group Business Overview
11.4.3 Avacta Group Central Nervous System Biomarkers Introduction
11.4.4 Avacta Group Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.4.5 Avacta Group Recent Development
11.5 Diagenic Asa
11.5.1 Diagenic Asa Company Details
11.5.2 Diagenic Asa Business Overview
11.5.3 Diagenic Asa Central Nervous System Biomarkers Introduction
11.5.4 Diagenic Asa Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.5.5 Diagenic Asa Recent Development
11.6 Banyan Biomarkers
11.6.1 Banyan Biomarkers Company Details
11.6.2 Banyan Biomarkers Business Overview
11.6.3 Banyan Biomarkers Central Nervous System Biomarkers Introduction
11.6.4 Banyan Biomarkers Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.6.5 Banyan Biomarkers Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Details
11.7.2 Eli Lilly Business Overview
11.7.3 Eli Lilly Central Nervous System Biomarkers Introduction
11.7.4 Eli Lilly Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.7.5 Eli Lilly Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Central Nervous System Biomarkers Introduction
11.8.4 Pfizer Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.8.5 Pfizer Recent Development
11.9 Alseres Pharmaceuticals
11.9.1 Alseres Pharmaceuticals Company Details
11.9.2 Alseres Pharmaceuticals Business Overview
11.9.3 Alseres Pharmaceuticals Central Nervous System Biomarkers Introduction
11.9.4 Alseres Pharmaceuticals Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.9.5 Alseres Pharmaceuticals Recent Development
11.10 Acumen pharmaceuticals
11.10.1 Acumen pharmaceuticals Company Details
11.10.2 Acumen pharmaceuticals Business Overview
11.10.3 Acumen pharmaceuticals Central Nervous System Biomarkers Introduction
11.10.4 Acumen pharmaceuticals Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.10.5 Acumen pharmaceuticals Recent Development
11.11 EKF Diagnostics
11.11.1 EKF Diagnostics Company Details
11.11.2 EKF Diagnostics Business Overview
11.11.3 EKF Diagnostics Central Nervous System Biomarkers Introduction
11.11.4 EKF Diagnostics Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.11.5 EKF Diagnostics Recent Development
11.12 Abiant
11.12.1 Abiant Company Details
11.12.2 Abiant Business Overview
11.12.3 Abiant Central Nervous System Biomarkers Introduction
11.12.4 Abiant Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.12.5 Abiant Recent Development
11.13 Myriad RBM
11.13.1 Myriad RBM Company Details
11.13.2 Myriad RBM Business Overview
11.13.3 Myriad RBM Central Nervous System Biomarkers Introduction
11.13.4 Myriad RBM Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.13.5 Myriad RBM Recent Development
11.14 Aposense
11.14.1 Aposense Company Details
11.14.2 Aposense Business Overview
11.14.3 Aposense Central Nervous System Biomarkers Introduction
11.14.4 Aposense Revenue in Central Nervous System Biomarkers Business (2020-2025)
11.14.5 Aposense Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Central Nervous System Biomarkers Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Safety Biomarker
Table 3. Key Players of Efficacy Biomarker
Table 4. Key Players of Validation Biomarker
Table 5. Key Players of Other
Table 6. Global Central Nervous System Biomarkers Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Central Nervous System Biomarkers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Central Nervous System Biomarkers Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Central Nervous System Biomarkers Market Share by Region (2020-2025)
Table 10. Global Central Nervous System Biomarkers Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Central Nervous System Biomarkers Market Share by Region (2026-2031)
Table 12. Central Nervous System Biomarkers Market Trends
Table 13. Central Nervous System Biomarkers Market Drivers
Table 14. Central Nervous System Biomarkers Market Challenges
Table 15. Central Nervous System Biomarkers Market Restraints
Table 16. Global Central Nervous System Biomarkers Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Central Nervous System Biomarkers Market Share by Players (2020-2025)
Table 18. Global Top Central Nervous System Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Biomarkers as of 2024)
Table 19. Ranking of Global Top Central Nervous System Biomarkers Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Central Nervous System Biomarkers Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Central Nervous System Biomarkers, Headquarters and Area Served
Table 22. Global Key Players of Central Nervous System Biomarkers, Product and Application
Table 23. Global Key Players of Central Nervous System Biomarkers, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Central Nervous System Biomarkers Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Central Nervous System Biomarkers Revenue Market Share by Type (2020-2025)
Table 27. Global Central Nervous System Biomarkers Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Central Nervous System Biomarkers Revenue Market Share by Type (2026-2031)
Table 29. Global Central Nervous System Biomarkers Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Central Nervous System Biomarkers Revenue Market Share by Application (2020-2025)
Table 31. Global Central Nervous System Biomarkers Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Central Nervous System Biomarkers Revenue Market Share by Application (2026-2031)
Table 33. North America Central Nervous System Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Central Nervous System Biomarkers Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Central Nervous System Biomarkers Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Central Nervous System Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Central Nervous System Biomarkers Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Central Nervous System Biomarkers Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Central Nervous System Biomarkers Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Central Nervous System Biomarkers Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Central Nervous System Biomarkers Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Central Nervous System Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Central Nervous System Biomarkers Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Central Nervous System Biomarkers Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Central Nervous System Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Central Nervous System Biomarkers Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Central Nervous System Biomarkers Market Size by Country (2026-2031) & (US$ Million)
Table 48. Merck Company Details
Table 49. Merck Business Overview
Table 50. Merck Central Nervous System Biomarkers Product
Table 51. Merck Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 52. Merck Recent Development
Table 53. Takeda Pharmaceutical Company Details
Table 54. Takeda Pharmaceutical Business Overview
Table 55. Takeda Pharmaceutical Central Nervous System Biomarkers Product
Table 56. Takeda Pharmaceutical Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 57. Takeda Pharmaceutical Recent Development
Table 58. Thermo Fisher Scientific Company Details
Table 59. Thermo Fisher Scientific Business Overview
Table 60. Thermo Fisher Scientific Central Nervous System Biomarkers Product
Table 61. Thermo Fisher Scientific Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 62. Thermo Fisher Scientific Recent Development
Table 63. Avacta Group Company Details
Table 64. Avacta Group Business Overview
Table 65. Avacta Group Central Nervous System Biomarkers Product
Table 66. Avacta Group Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 67. Avacta Group Recent Development
Table 68. Diagenic Asa Company Details
Table 69. Diagenic Asa Business Overview
Table 70. Diagenic Asa Central Nervous System Biomarkers Product
Table 71. Diagenic Asa Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 72. Diagenic Asa Recent Development
Table 73. Banyan Biomarkers Company Details
Table 74. Banyan Biomarkers Business Overview
Table 75. Banyan Biomarkers Central Nervous System Biomarkers Product
Table 76. Banyan Biomarkers Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 77. Banyan Biomarkers Recent Development
Table 78. Eli Lilly Company Details
Table 79. Eli Lilly Business Overview
Table 80. Eli Lilly Central Nervous System Biomarkers Product
Table 81. Eli Lilly Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 82. Eli Lilly Recent Development
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Central Nervous System Biomarkers Product
Table 86. Pfizer Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 87. Pfizer Recent Development
Table 88. Alseres Pharmaceuticals Company Details
Table 89. Alseres Pharmaceuticals Business Overview
Table 90. Alseres Pharmaceuticals Central Nervous System Biomarkers Product
Table 91. Alseres Pharmaceuticals Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 92. Alseres Pharmaceuticals Recent Development
Table 93. Acumen pharmaceuticals Company Details
Table 94. Acumen pharmaceuticals Business Overview
Table 95. Acumen pharmaceuticals Central Nervous System Biomarkers Product
Table 96. Acumen pharmaceuticals Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 97. Acumen pharmaceuticals Recent Development
Table 98. EKF Diagnostics Company Details
Table 99. EKF Diagnostics Business Overview
Table 100. EKF Diagnostics Central Nervous System Biomarkers Product
Table 101. EKF Diagnostics Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 102. EKF Diagnostics Recent Development
Table 103. Abiant Company Details
Table 104. Abiant Business Overview
Table 105. Abiant Central Nervous System Biomarkers Product
Table 106. Abiant Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 107. Abiant Recent Development
Table 108. Myriad RBM Company Details
Table 109. Myriad RBM Business Overview
Table 110. Myriad RBM Central Nervous System Biomarkers Product
Table 111. Myriad RBM Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 112. Myriad RBM Recent Development
Table 113. Aposense Company Details
Table 114. Aposense Business Overview
Table 115. Aposense Central Nervous System Biomarkers Product
Table 116. Aposense Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 117. Aposense Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Central Nervous System Biomarkers Picture
Figure 2. Global Central Nervous System Biomarkers Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Central Nervous System Biomarkers Market Share by Type: 2024 VS 2031
Figure 4. Safety Biomarker Features
Figure 5. Efficacy Biomarker Features
Figure 6. Validation Biomarker Features
Figure 7. Other Features
Figure 8. Global Central Nervous System Biomarkers Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Central Nervous System Biomarkers Market Share by Application: 2024 VS 2031
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Central Nervous System Biomarkers Report Years Considered
Figure 14. Global Central Nervous System Biomarkers Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Central Nervous System Biomarkers Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Central Nervous System Biomarkers Market Share by Region: 2024 VS 2031
Figure 17. Global Central Nervous System Biomarkers Market Share by Players in 2024
Figure 18. Global Top Central Nervous System Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Biomarkers as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Central Nervous System Biomarkers Revenue in 2024
Figure 20. North America Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Central Nervous System Biomarkers Market Share by Country (2020-2031)
Figure 22. United States Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Central Nervous System Biomarkers Market Share by Country (2020-2031)
Figure 26. Germany Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Central Nervous System Biomarkers Market Share by Region (2020-2031)
Figure 34. China Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Central Nervous System Biomarkers Market Share by Country (2020-2031)
Figure 42. Mexico Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Central Nervous System Biomarkers Market Share by Country (2020-2031)
Figure 46. Turkey Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Merck Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 50. Takeda Pharmaceutical Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 52. Avacta Group Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 53. Diagenic Asa Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 54. Banyan Biomarkers Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 55. Eli Lilly Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 56. Pfizer Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 57. Alseres Pharmaceuticals Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 58. Acumen pharmaceuticals Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 59. EKF Diagnostics Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 60. Abiant Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 61. Myriad RBM Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 62. Aposense Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Central Nervous System Biomarkers Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Safety Biomarker
Table 3. Key Players of Efficacy Biomarker
Table 4. Key Players of Validation Biomarker
Table 5. Key Players of Other
Table 6. Global Central Nervous System Biomarkers Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Central Nervous System Biomarkers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Central Nervous System Biomarkers Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Central Nervous System Biomarkers Market Share by Region (2020-2025)
Table 10. Global Central Nervous System Biomarkers Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Central Nervous System Biomarkers Market Share by Region (2026-2031)
Table 12. Central Nervous System Biomarkers Market Trends
Table 13. Central Nervous System Biomarkers Market Drivers
Table 14. Central Nervous System Biomarkers Market Challenges
Table 15. Central Nervous System Biomarkers Market Restraints
Table 16. Global Central Nervous System Biomarkers Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Central Nervous System Biomarkers Market Share by Players (2020-2025)
Table 18. Global Top Central Nervous System Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Biomarkers as of 2024)
Table 19. Ranking of Global Top Central Nervous System Biomarkers Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Central Nervous System Biomarkers Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Central Nervous System Biomarkers, Headquarters and Area Served
Table 22. Global Key Players of Central Nervous System Biomarkers, Product and Application
Table 23. Global Key Players of Central Nervous System Biomarkers, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Central Nervous System Biomarkers Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Central Nervous System Biomarkers Revenue Market Share by Type (2020-2025)
Table 27. Global Central Nervous System Biomarkers Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Central Nervous System Biomarkers Revenue Market Share by Type (2026-2031)
Table 29. Global Central Nervous System Biomarkers Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Central Nervous System Biomarkers Revenue Market Share by Application (2020-2025)
Table 31. Global Central Nervous System Biomarkers Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Central Nervous System Biomarkers Revenue Market Share by Application (2026-2031)
Table 33. North America Central Nervous System Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Central Nervous System Biomarkers Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Central Nervous System Biomarkers Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Central Nervous System Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Central Nervous System Biomarkers Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Central Nervous System Biomarkers Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Central Nervous System Biomarkers Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Central Nervous System Biomarkers Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Central Nervous System Biomarkers Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Central Nervous System Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Central Nervous System Biomarkers Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Central Nervous System Biomarkers Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Central Nervous System Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Central Nervous System Biomarkers Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Central Nervous System Biomarkers Market Size by Country (2026-2031) & (US$ Million)
Table 48. Merck Company Details
Table 49. Merck Business Overview
Table 50. Merck Central Nervous System Biomarkers Product
Table 51. Merck Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 52. Merck Recent Development
Table 53. Takeda Pharmaceutical Company Details
Table 54. Takeda Pharmaceutical Business Overview
Table 55. Takeda Pharmaceutical Central Nervous System Biomarkers Product
Table 56. Takeda Pharmaceutical Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 57. Takeda Pharmaceutical Recent Development
Table 58. Thermo Fisher Scientific Company Details
Table 59. Thermo Fisher Scientific Business Overview
Table 60. Thermo Fisher Scientific Central Nervous System Biomarkers Product
Table 61. Thermo Fisher Scientific Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 62. Thermo Fisher Scientific Recent Development
Table 63. Avacta Group Company Details
Table 64. Avacta Group Business Overview
Table 65. Avacta Group Central Nervous System Biomarkers Product
Table 66. Avacta Group Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 67. Avacta Group Recent Development
Table 68. Diagenic Asa Company Details
Table 69. Diagenic Asa Business Overview
Table 70. Diagenic Asa Central Nervous System Biomarkers Product
Table 71. Diagenic Asa Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 72. Diagenic Asa Recent Development
Table 73. Banyan Biomarkers Company Details
Table 74. Banyan Biomarkers Business Overview
Table 75. Banyan Biomarkers Central Nervous System Biomarkers Product
Table 76. Banyan Biomarkers Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 77. Banyan Biomarkers Recent Development
Table 78. Eli Lilly Company Details
Table 79. Eli Lilly Business Overview
Table 80. Eli Lilly Central Nervous System Biomarkers Product
Table 81. Eli Lilly Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 82. Eli Lilly Recent Development
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Central Nervous System Biomarkers Product
Table 86. Pfizer Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 87. Pfizer Recent Development
Table 88. Alseres Pharmaceuticals Company Details
Table 89. Alseres Pharmaceuticals Business Overview
Table 90. Alseres Pharmaceuticals Central Nervous System Biomarkers Product
Table 91. Alseres Pharmaceuticals Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 92. Alseres Pharmaceuticals Recent Development
Table 93. Acumen pharmaceuticals Company Details
Table 94. Acumen pharmaceuticals Business Overview
Table 95. Acumen pharmaceuticals Central Nervous System Biomarkers Product
Table 96. Acumen pharmaceuticals Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 97. Acumen pharmaceuticals Recent Development
Table 98. EKF Diagnostics Company Details
Table 99. EKF Diagnostics Business Overview
Table 100. EKF Diagnostics Central Nervous System Biomarkers Product
Table 101. EKF Diagnostics Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 102. EKF Diagnostics Recent Development
Table 103. Abiant Company Details
Table 104. Abiant Business Overview
Table 105. Abiant Central Nervous System Biomarkers Product
Table 106. Abiant Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 107. Abiant Recent Development
Table 108. Myriad RBM Company Details
Table 109. Myriad RBM Business Overview
Table 110. Myriad RBM Central Nervous System Biomarkers Product
Table 111. Myriad RBM Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 112. Myriad RBM Recent Development
Table 113. Aposense Company Details
Table 114. Aposense Business Overview
Table 115. Aposense Central Nervous System Biomarkers Product
Table 116. Aposense Revenue in Central Nervous System Biomarkers Business (2020-2025) & (US$ Million)
Table 117. Aposense Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Central Nervous System Biomarkers Picture
Figure 2. Global Central Nervous System Biomarkers Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Central Nervous System Biomarkers Market Share by Type: 2024 VS 2031
Figure 4. Safety Biomarker Features
Figure 5. Efficacy Biomarker Features
Figure 6. Validation Biomarker Features
Figure 7. Other Features
Figure 8. Global Central Nervous System Biomarkers Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Central Nervous System Biomarkers Market Share by Application: 2024 VS 2031
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Central Nervous System Biomarkers Report Years Considered
Figure 14. Global Central Nervous System Biomarkers Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Central Nervous System Biomarkers Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Central Nervous System Biomarkers Market Share by Region: 2024 VS 2031
Figure 17. Global Central Nervous System Biomarkers Market Share by Players in 2024
Figure 18. Global Top Central Nervous System Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Biomarkers as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Central Nervous System Biomarkers Revenue in 2024
Figure 20. North America Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Central Nervous System Biomarkers Market Share by Country (2020-2031)
Figure 22. United States Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Central Nervous System Biomarkers Market Share by Country (2020-2031)
Figure 26. Germany Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Central Nervous System Biomarkers Market Share by Region (2020-2031)
Figure 34. China Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Central Nervous System Biomarkers Market Share by Country (2020-2031)
Figure 42. Mexico Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Central Nervous System Biomarkers Market Share by Country (2020-2031)
Figure 46. Turkey Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Central Nervous System Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Merck Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 50. Takeda Pharmaceutical Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 52. Avacta Group Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 53. Diagenic Asa Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 54. Banyan Biomarkers Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 55. Eli Lilly Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 56. Pfizer Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 57. Alseres Pharmaceuticals Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 58. Acumen pharmaceuticals Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 59. EKF Diagnostics Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 60. Abiant Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 61. Myriad RBM Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 62. Aposense Revenue Growth Rate in Central Nervous System Biomarkers Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global UV Delayed Curing Adhesives Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Die-Casting Die Steel Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232